Medical device company Coloplast A/S (CPH:COLOB), a provider of medical devices and services related to ostomy, urology, continence and wound care, announced on Tuesday the availability of the new SenSura Mio Convex Flip in the US.
The company said it has expanded its SenSura Mio ostomy range with the new, innovative, first-of-its-kind SenSura Mio Convex Flip ostomy product.
Designed specifically for the outward body shapes, and the first of its kind in the ostomy market, the SenSura Mio ostomy care portfolio is intended to meet the differing needs of ostomates through its BodyFit Technology. Flat and convex barriers are common, which the SenSura Mio offers a solution for.
According to the company, SenSura Mio Convex Flip is a new solution for people with an outward body profile and is the first ostomy appliance designed specifically for those that are overweight, obese, or have parastomal bulges or hernias.
Coloplast added that with the addition of SenSura Mio Convex Flip, it continues to build out its ostomy SenSura Mio portfolio to meet more people's needs. It is difficult to make a great fit for people with outward body profiles, but the curved, star-shaped barrier can do just that.
BD receives FDA clearance for Surgiphor 1000mL irrigation system
Galderma secures EU, US and Canada approval for new Restylane syringe
Organon licenses MIUDELLA IUD from Sebela Pharmaceuticals
Advita Ortho updates Chime clinical exchange application
Philips launches InkSpace Imaging Snuggle coil for 3.0T MRI systems
Realheart secures European patent for artificial heart technology
Median Technologies secures FDA clearance for AI lung cancer screening software
Eli Lilly to invest over USD3.5bn in new Pennsylvania plant
Spine Innovation's LOGIC Titanium Implant System receives US FDA 510(k) market approval
Apiject to open new generic injectable drug manufacturing facility in Apex, NC
Zylox-Tonbridge agrees staged acquisition of Germany's Optimed
Kestra partners with Biobeat to add cuffless blood pressure monitoring to wearable defibrillator
Boston Scientific to acquire Valencia Technologies to expand overactive bladder portfolio
EQT Life Sciences exits Vivasure Medical in EUR185m sale to Haemonetics
Saluda Medical secures CE certification for EVA Sensing Technology in Europe